Viewing Study NCT06543069


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-02-25 @ 4:38 PM
Study NCT ID: NCT06543069
Status: RECRUITING
Last Update Posted: 2024-08-07
First Post: 2024-08-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Sponsor:
Organization: